A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host disease.
Blood
; 141(11): 1277-1292, 2023 03 16.
Article
in En
| MEDLINE
| ID: mdl-36044666
Full text:
1
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
Mesenchymal Stem Cell Transplantation
/
Graft vs Host Disease
Type of study:
Prognostic_studies
Limits:
Child
/
Humans
Language:
En
Journal:
Blood
Year:
2023
Type:
Article
Affiliation country:
Netherlands